In PASC-SFN, specific biomarkers were rarely investigated or were not specific, except for McAlpine et al. who found in almost 30% of TS-HDS/FGFR-3 autoantibodies patients [15], although their exact pathophysiological role in the peripheral nervous system has not been definitely demonstrated. This evidence concerns the gene FGFR3 and long COVID-19.